Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


02.07.2018

2 Acta Neurol Scand
1 Arch Phys Med Rehabil
5 J Neuroimmunol
1 J Neurol Sci
2 Mult Scler
2 Neurology
2 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
    Real-life clinical use of natalizumab and fingolimod in Austria.
    Acta Neurol Scand. 2018;137:181-187.
    PubMed     Text format     Abstract available

  2. NICKEL S, von dem Knesebeck O, Kofahl C
    Self-assessments and determinants of HRQoL in a German MS population.
    Acta Neurol Scand. 2018;137:174-180.
    PubMed     Text format     Abstract available


    Arch Phys Med Rehabil

  3. MARTINI DN, Zeeboer E, Hildebrand A, Fling BW, et al
    ADSTEP: Preliminary investigation of a multicomponent walking aid program in people with multiple sclerosis.
    Arch Phys Med Rehabil. 2018 Jun 26. pii: S0003-9993(18)30382.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  4. FAGONE P, Mazzon E, Cavalli E, Bramanti A, et al
    Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences.
    J Neuroimmunol. 2018 Jun 15. pii: S0165-5728(18)30141.
    PubMed     Text format     Abstract available

  5. SABERI R, Sharif M, Sarvi S, Aghayan SA, et al
    Is Toxoplasma gondii playing a positive role in multiple sclerosis risk? A systematic review and meta-analysis.
    J Neuroimmunol. 2018 Jun 22. pii: S0165-5728(17)30579.
    PubMed     Text format     Abstract available

  6. MOHAJER B, Abbasi N, Pishgar F, Abdolalizadeh A, et al
    HLA-DRB1 polymorphism and susceptibility to multiple sclerosis in the Middle East North Africa region: A systematic review and meta-analysis.
    J Neuroimmunol. 2018;321:117-124.
    PubMed     Text format     Abstract available

  7. LAI W, Kinoshita M, Peng A, Li W, et al
    Does pregnancy affect women with multiple sclerosis? A prospective study in Western China.
    J Neuroimmunol. 2018;321:24-28.
    PubMed     Text format     Abstract available

  8. FEKI S, Gargouri S, Mejdoub S, Dammak M, et al
    The intrathecal polyspecific antiviral immune response (MRZ reaction): A potential cerebrospinal fluid marker for multiple sclerosis diagnosis.
    J Neuroimmunol. 2018;321:66-71.
    PubMed     Text format     Abstract available


    J Neurol Sci

  9. GROMISCH ES, Portnoy JG, Foley FW
    Response to screening ability of cognitive function by two measures in patients with multiple sclerosis.
    J Neurol Sci. 2018 Jun 14. pii: S0022-510X(18)30259.
    PubMed     Text format    


    Mult Scler

  10. GALLAGHER LG, Ilango S, Wundes A, Stobbe GA, et al
    Lifetime exposure to ultraviolet radiation and the risk of multiple sclerosis in the US radiologic technologists cohort study.
    Mult Scler. 2018 Jun 1:1352458518783343. doi: 10.1177/1352458518783343.
    PubMed     Text format     Abstract available

  11. MAGALHAES S, Banwell B, Bar-Or A, Fortier I, et al
    A framework for measurement and harmonization of pediatric multiple sclerosis etiologic research studies: The Pediatric MS Tool-Kit.
    Mult Scler. 2018 Jun 1:1352458518783345. doi: 10.1177/1352458518783345.
    PubMed     Text format     Abstract available


    Neurology

  12. TSAGKAS C, Magon S, Gaetano L, Pezold S, et al
    Spinal cord volume loss: A marker of disease progression in multiple sclerosis.
    Neurology. 2018 Jun 27. pii: WNL.0000000000005853.
    PubMed     Text format     Abstract available

  13. PRADOS F, Barkhof F
    Spinal cord atrophy rates: Ready for prime time in multiple sclerosis clinical trials?
    Neurology. 2018 Jun 27. pii: WNL.0000000000005873.
    PubMed     Text format    


    PLoS One

  14. PARKER HARP CR, Archambault AS, Sim J, Shlomchik MJ, et al
    B cells are capable of independently eliciting rapid reactivation of encephalitogenic CD4 T cells in a murine model of multiple sclerosis.
    PLoS One. 2018;13:e0199694.
    PubMed     Text format     Abstract available

  15. RAHIMI F, Rasekh HR, Abbasian E, Peiravian F, et al
    Patient preferences for Interferon-beta in Iran: A discrete choice experiment.
    PLoS One. 2018;13:e0193090.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: